What is Benitec Biopharma Ltd ADR (BNTC) stock price today?

Benitec Biopharma Ltd ADR (BNTC) currently trades at $12.05 per share. The stock has a market capitalization of $423.73M and a P/E ratio of —x.

Is BNTC stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Benitec Biopharma Ltd ADR has a Smart Value Score of 32/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Benitec Biopharma Ltd ADR's revenue and earnings?

Benitec Biopharma Ltd ADR has trailing twelve-month (TTM) revenue of $7000.00 with profit margins of 0.00%. Earnings per share (EPS) is $-1.08.

BNTC

Benitec Biopharma Ltd ADR

NASDAQ: BNTC · HEALTHCARE · BIOTECHNOLOGY

$12.05

-0.82% today

Updated 2026-04-30

Market cap

$423.73M

P/E ratio

—

P/S ratio

2,770.13x

EPS (TTM)

$-1.08

Dividend yield

—

52W range

$10 – $17

Volume

0.2M

Market cap

$423.73M

P/E ratio

—

P/S ratio

2,770.13x

EPS (TTM)

$-1.08

Dividend yield

—

52W range

$10 – $17

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

5.0

Growth

C+

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$24.17

+100.58%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 12.50% QoQ

Risks

- Thin margins at 0.00%

- Negative free cash flow $-3.79M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$73000.00	$75000.00	$216000.00	$0.00	$7000.00
Net income	$-18.21M	$-19.56M	$-21.75M	$-37.92M	$-11.84M
EPS	—	—	—	—	$-1.08
Free cash flow	$-15.91M	$-18.01M	$-19.58M	$-23.61M	$-3.79M
Profit margin	-24,942.47%	-26,082.67%	-10,069.91%	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
BNTC	$423.73M	32	5.0	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Benitec Biopharma Ltd ADR trades at $12.05. Our Smart Value Score of 32/100 indicates the stock is weak. TTM revenue stands at $7000.00.

Frequently asked questions

What is Benitec Biopharma Ltd ADR's stock price?

Benitec Biopharma Ltd ADR (BNTC) trades at $12.05.

Is Benitec Biopharma Ltd ADR overvalued?

Smart Value Score 32/100 (Grade F, Strong Sell).

What is the price target of Benitec Biopharma Ltd ADR (BNTC)?

The analyst target price is $24.17, representing +100.6% upside from the current price of $12.05.

What is Benitec Biopharma Ltd ADR's revenue?

TTM revenue is $7000.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio2,770.13x

ROE-33.50%

Beta0.12

50D MA$11.51

200D MA$12.69

Shares out0.03B

Float0.02B

Short ratio—

Avg volume0.2M

Performance

1 week-6.10%

1 month+20.97%

3 months+0.75%

YTD-9.65%

1 year—

3 years—

5 years—

Compare

BNTC vs LLY →BNTC vs JNJ →BNTC vs ABBV →Stock screener →